Oussama Abla, MD

The Hospital for Sick Children and University of Toronto

Division of Hematology/Oncology

Toronto, ON

Canada

Francesco Lo-Coco, MD

Professor of Hematology

Rome

Miguel A. Sanz, MD

Centro de Investigacio¿n Biome¿dica en Red de Cäncer

Madrid

Spain

First comprehensive text on acute promyelocytic leukemia in the last ten years

Summarizes historical, current, and future treatment strategies

Highlights the most recent therapeutic recommendations for relapsed disease

Written by top experts in the field

History of APL.- Molecular Targets of Treatment in APL.- The Leukemic Stem Cell.- The Molecular Genetics of APL.- APL Coagulopathy.- Early Death in APL.- Prognostic Factors in APL.- First-line therapy for APL: Chemotherapy-based approach.- First-line Therapy: ATRA-ATO/Reduced Chemotherapy Approach.- Cure of APL without Chemotherapy.- Minimal Residual Disease in APL.- Treatment of refractory and relapsed APL.- Hematopoietic Stem Cell Transplantation in APL.- APL in Children.- Management of APL in the Elderly.- Special Situations in APL.- APL in Developing Countries: A Chemotherapy-Based Approach.- APL in Developing Countries: ATO based Approach.- Therapy-Related APL.- Rare Acute Leukemia Variants involving Retinoic Acid Receptor Genes.- Management of Treatment-Related Complications in APL.